2023
DOI: 10.1007/s00894-023-05521-8
|View full text |Cite
|
Sign up to set email alerts
|

Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 109 publications
0
1
0
Order By: Relevance
“…The drug-likeness and pharmacokinetic (ADMET) profiles of the synthesized phenylhydrazono phenoxyquinoline derivatives ( 5a - 5x ) were estimated utilizing the online SwissADME and pkCSM servers. , Various criteria from a set of rules, including Lipinski’s rule (Ro5), Veber’s rule, Ghose’s rule, Egan’s rule, and Muegge’s rule, were considered to estimate the drug-likeness profile of synthesized phenylhydrazono phenoxyquinoline derivatives ( 5a – 5k ). …”
Section: Methodsmentioning
confidence: 99%
“…The drug-likeness and pharmacokinetic (ADMET) profiles of the synthesized phenylhydrazono phenoxyquinoline derivatives ( 5a - 5x ) were estimated utilizing the online SwissADME and pkCSM servers. , Various criteria from a set of rules, including Lipinski’s rule (Ro5), Veber’s rule, Ghose’s rule, Egan’s rule, and Muegge’s rule, were considered to estimate the drug-likeness profile of synthesized phenylhydrazono phenoxyquinoline derivatives ( 5a – 5k ). …”
Section: Methodsmentioning
confidence: 99%